Plasmalyte + Glucose 5% otopina za infuziju
| Name | Plasmalyte + Glucose 5% otopina za infuziju |
|---|---|
| Marketing Authorisation Number | HR-H-601830731 |
| Active Substance | glukoza hidrat natrijev klorid kalijev klorid magnezijev klorid heksahidrat natrijev acetat trihidrat natrijev glukonat |
| Composition | 1000 ml otopine za infuziju sadrži: 55,00 g glukoze (u obliku glukoza hidrata), 5,26 g natrijeva klorida, 0,37 g kalijeva klorida, 0,30 g magnezijeva klorid heksahidrata, 3,68 g natrijeva acetat trihidrata i 5,02 g natrijeva glukonata |
| Pharmaceutical Form | Otopina za infuziju |
| Manufacturer | Baxter S.A., Lessines, Belgija
Bieffe Medital S.A., Sabinanigo (Huesca), Španjolska |
| Marketing Authorisation Holder | Baxter d.o.o., Letališka cesta 29A, Ljubljana, Slovenija |
| Marketing Authorisation Date | 28.02.2025 |
| MA Period of Validity | 28.02.2030 |
| Classification Number | UP/I-530-09/24-01/98 |
| Registration Number | 381-12-01/286-25-12 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product subject to restricted medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | B05BB02 |
| Marketing status | Never marketed |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |